Add BrightSurf on Google Email

University of California - San Diego


A cancer marker and treatment in 1?

Researchers at UC San Diego School of Medicine have discovered a potential cancer biomarker in non-human sialic acid antibodies, which can also be used as a treatment to suppress tumor growth. The study found that patients with carcinomas have elevated levels of antibodies to one specific Neu5Gc-containing sugar chain.

SourceUniversity of California - San Diego·JournalCancer Research·DateApr 19, 2011

Vision loss in eye disease slowed using novel encapsulated cell therapy

A phase 2 clinical trial demonstrates the benefit of a neurotrophic factor to treat geographic atrophy, a severe form of age-related macular degeneration. The therapy, which delivers ciliary neurotrophic factor using encapsulated cell therapy, slowed vision loss and stabilized vision in patients with high-dose treatment.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateApr 6, 2011

Call of the riled

Researchers discovered that cancer cells generate a 'stress response' signal that induces nearby macrophages to issue a similar stress response, promoting inflammation and tumor development. This finding presents a potential target for tumor-specific therapies.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateApr 4, 2011

Primordial soup gets spicier

Researchers have reanalyzed Stanley Miller's 1958 'primordial soup' samples and found a diverse array of organic compounds, including sulfur amino acids. The discovery supports the hypothesis that volcanoes and lightning played a key role in creating the building blocks of life on Earth.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateMar 21, 2011

Searching for the soul of the genome

Researchers at the University of California, San Diego, develop novel method to detect long-distance chromosomal interactions and find association with CAD risk from altered inflammatory signaling response. The study identifies 33 regulatory elements in the 9p21 interval involved in cellular signaling and response to inflammation.

The hitch in the drug? The itch in the drug

Researchers identify two distinct neuronal signaling pathways activated by Imiquimod, a topical cream that treats skin diseases while inducing severe itching as a side effect. The study may lead to designing future drugs that effectively treat targeted conditions while blocking problematic itching and scratching.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateFeb 8, 2011

Babies process language in a grown-up way

Researchers at UC San Diego found that babies over a year old process words with adult-like brain structures and meanings, challenging previous theories on infant language development. The study used MEG and MRI to map brain activity in infants and confirmed the same left frontotemporal areas activated in adults for word meaning.

SourceUniversity of California - San Diego·JournalCerebral Cortex·DateJan 6, 2011

Researchers discover new signaling pathway linked to inflammatory disease

Researchers have identified a key inhibitory role for the IL-1 signaling pathway in the human innate immune system, revealing its impact on inflammatory bowel disease (IBD) and anti-inflammatory cytokine production. The study suggests that certain drugs used to treat conditions like rheumatoid arthritis may be harmful to IBD patients.

SourceUniversity of California - San Diego·JournalJournal of Experimental Medicine·DateDec 14, 2010